PUBLIC COMPANY
saveELI LILLY CO
USupdated 4mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spreeRA Capital has already participated in four biotech financings in September. Meanwhile, Janus Henderson has been the year's most prolific backer of biotech reverse merger deals, according to Gilmar…biopharma_dive · 1d ago
- Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra useKaryopharm bought an extra month to negotiate with creditors or pursue a deal. Elsewhere, BridgeBio Pharma’s oncology spinout shook up its development plans and a brain-focused gene therapy startup…biopharma_dive · 1d ago
- Frazier adds $1.1B+ to small and mid-sized biotech fundFrazier’s life science fund has already benefited several successful biotechs, including Verona Pharma, which was acquired by Merck for $10 billion, and Carmot Therapeutics, which Roche bought for…biospace · 1d ago
- Novartis drags peers down with triple asset failureNovartis’ shares fell 13% this week after the report of three separate late-stage asset failures. The impact went beyond the Swiss drugmaker, dragging peers down across the market.biospace · 1d ago
- Novartis drags peers down with triple asset stumbleNovartis’ shares fell 13% this week after the report of three separate late-stage asset setbacks. The impact went beyond the Swiss drugmaker, dragging peers down across the market.biospace · 1d ago
- Novartis’ board faces investor scrutiny after M&A misfires and R&D flopsBack-to-back failures of multiple late-phase trials have raised questions about how Novartis has deployed capital in pursuit of drugs to drive growth through the 2030s.biospace · 1d ago
- Why two promising heart drugs flopped and what’s nextThis week on "The Readout LOUD" podcast: Two experimental drugs were heralded as the next era in heart disease treatment — why did they fail?stat · 2d ago
- 11 companies hiring in California nowLooking for a biopharma job in California? Check out the BioSpace list of 11 companies hiring life sciences professionals like you.biospace · 2d ago
- Merck adds 53 to New Jersey chopping blockFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 2d ago
- Kura spins diabetes work into a Lilly-backed biotech startupCaspian Therapeutics aims to develop menin inhibitors, which have proven effective against leukemia, for diabetes and other cardiometabolic conditions.biopharma_dive · 3d ago
comments(0)
5-min edit window · permanent after that